Theravance Biopharma Inc. (TBPH)
NASDAQ · Healthcare
Theravance Biopharma Inc. Gross Profit 2012–2025
Theravance Biopharma Inc. annual/quarterly gross profit history and growth rate from 2012 to 2017. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Theravance Biopharma Inc. gross profit for the quarter ending September 30, 2017 was 3.3 M, a 82.45% decrease year-over-year.
- Theravance Biopharma Inc. gross profit for the twelve months ending September 30, 2017 was 26.7 M, a 31.91% decrease year-over-year.
- Theravance Biopharma Inc. annual gross profit for 2017 was 9.4 M, a 79.55% decrease from 2016.
- Theravance Biopharma Inc. annual gross profit for 2016 was 45.8 M, a 22.11% increase from 2015.
- Theravance Biopharma Inc. annual gross profit for 2015 was 37.5 M, a 391.07% increase from 2014.
- Theravance Biopharma Inc. annual gross profit for 2014 was 7.6 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Theravance Biopharma Inc. Gross Profit — FAQ
Theravance Biopharma Inc. (TBPH) gross profit over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TBPH's gross profit history?
The chart and table above show Theravance Biopharma Inc.'s gross profit by year and by quarter, including the growth rate.